Home › Funds › ACORN CAPITAL ADVISORS, LLC › TRVI

ACORN CAPITAL ADVISORS, LLC position in TRVI

TREVI THERAPEUTICS INC · Health Care

ACORN CAPITAL ADVISORS, LLC reported holding 2,144,844 shares of TRVI (TREVI THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$30.7M, representing 8.44% of its reported portfolio and ranking #5 among its reported holdings. ACORN CAPITAL ADVISORS, LLC has disclosed TRVI holdings in 8 of the last 8 reported quarters, going back to Q4 2024.

Latest position (Q3 2026)2.14M sh
Reported value held$30.71M
Portfolio Weight8.44%
First reportedQ4 2024
Last changeHold
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How ACORN CAPITAL ADVISORS, LLC's TRVI position evolved

ACORN CAPITAL ADVISORS, LLC first disclosed a stake in TRVI in Q4 2024 at 2,001,048 shares (US$8.2M). The position peaked in Q2 2026 at 2,144,844 shares, worth US$40.0M. Across 8 filings, ACORN CAPITAL ADVISORS, LLC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 6 time(s). The most recent filing (Q3 2026) shows 2,144,844 shares valued at US$30.7M.

Quarter by quarter

QuarterSharesValueChange
Q4 2024 2.00M $8.24M New
Q1 2025 2.14M $13.49M Add
Q2 2025 2.14M $11.73M Hold
Q3 2025 2.14M $19.63M Hold
Q4 2025 2.14M $26.85M Hold
Q1 2026 2.14M $25.59M Hold
Q2 2026 2.14M $40.00M Hold
Q3 2026 2.14M $30.71M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About TRVI and 13F data

TRVI (TREVI THERAPEUTICS INC) is a Health Care company. 58 other funds we track also report a position in TRVI — the largest reported positions include NEA Management Company, LLC (US$246.6M), Frazier Life Sciences Management, L.P. (US$185.4M), Vivo Capital, LLC (US$60.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding TRVI

All TRVI fund holders →

FAQ

How long has ACORN CAPITAL ADVISORS, LLC held TRVI?

ACORN CAPITAL ADVISORS, LLC has disclosed TRVI holdings in 8 of the last 8 reported quarters, going back to Q4 2024.

What is ACORN CAPITAL ADVISORS, LLC's current position in TRVI?

As of Q3 2026, ACORN CAPITAL ADVISORS, LLC holds 2.14M shares of TRVI (TREVI THERAPEUTICS INC), valued at $30.71M, representing 8.44% of its reported portfolio and ranking #5.

Has ACORN CAPITAL ADVISORS, LLC been buying or selling TRVI?

In the latest 13F filing (Q3 2026), ACORN CAPITAL ADVISORS, LLC held unchanged its position in TRVI. The position peaked in Q2 2026 at 2.14M shares.

Which other funds hold TRVI?

Other major institutional holders of TRVI include NEA Management Company, LLC, Frazier Life Sciences Management, L.P., Vivo Capital, LLC, among 58 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.